Global Osteoarthritis Pain Market Insights, Forecast to 2025

Published On: February 2020 | Report ID: 18874 | Category: Medical DevicesPages: 165

Osteoarthritis, the most common type of arthritis, is a leading cause of disability.

It is also known as degenerative joint disease, hypertrophic arthritis, and degenerative arthritis, and is most commonly prevalent in older (above 60 years of age) and middle-aged people (between 40-59 years of age).

The global Osteoarthritis Pain market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Osteoarthritis Pain market based on company, product type, end user and key regions.

This report studies the global market size of Osteoarthritis Pain in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Osteoarthritis Pain in these regions.

This research report categorizes the global Osteoarthritis Pain market by top players/brands, region, type and end user. This report also studies the global Osteoarthritis Pain market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

Abbott Laboratories

Johnson & Johnson

Novartis International

Pfizer

AbbVie

Abiogen Pharma

Afferent Pharmaceuticals

Astellas Pharma

BioDelivery Sciences International

Crystal Genomics

Cytori Therapeutics

Market size by Product

Oral

Non-Oral

Market size by End User

Hospital

Pharmacy

Other

Market size by Region

North America

United States

Canada

Mexico

Asia-Pacific

China

India

Japan

South Korea

Australia

Indonesia

Singapore

Malaysia

Philippines

Thailand

Vietnam

Europe

Germany

France

UK

Italy

Spain

Russia

Central & South America

Brazil

Rest of Central & South America

Middle East & Africa

GCC Countries

Turkey

Egypt

South Africa

The study objectives of this report are:

To study and analyze the global Osteoarthritis Pain market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

To understand the structure of Osteoarthritis Pain market by identifying its various subsegments.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

Focuses on the key global Osteoarthritis Pain companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

To project the value and sales volume of Osteoarthritis Pain submarkets, with respect to key regions.

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Osteoarthritis Pain are as follows:

History Year: 2014-2018

Base Year: 2018

Estimated Year: 2019

Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Osteoarthritis Pain market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage

1.1 Osteoarthritis Pain Product

1.2 Market Segments

1.3 Key Manufacturers Covered

1.4 Market by Type

1.4.1 Global Osteoarthritis Pain Market Size Growth Rate by Product

1.4.2 Oral

1.4.3 Non-Oral

1.5 Market by End User

1.5.1 Global Osteoarthritis Pain Market Size Growth Rate by End User

1.5.2 Hospital

1.5.3 Pharmacy

1.5.4 Other

1.6 Study Objectives

1.7 Years Considered

2 Executive Summary

2.1 Global Osteoarthritis Pain Market Size

2.1.1 Global Osteoarthritis Pain Revenue 2014-2025

2.1.2 Global Osteoarthritis Pain Sales 2014-2025

2.2 Osteoarthritis Pain Growth Rate by Regions

2.2.1 Global Osteoarthritis Pain Sales by Regions

2.2.2 Global Osteoarthritis Pain Revenue by Regions

3 Breakdown Data by Manufacturers

3.1 Osteoarthritis Pain Sales by Manufacturers

3.1.1 Osteoarthritis Pain Sales by Manufacturers

3.1.2 Osteoarthritis Pain Sales Market Share by Manufacturers

3.1.3 Global Osteoarthritis Pain Market Concentration Ratio (CR5 and HHI)

3.2 Osteoarthritis Pain Revenue by Manufacturers

3.2.1 Osteoarthritis Pain Revenue by Manufacturers (2014-2019)

3.2.2 Osteoarthritis Pain Revenue Share by Manufacturers (2014-2019)

3.3 Osteoarthritis Pain Price by Manufacturers

3.4 Osteoarthritis Pain Manufacturing Base Distribution, Product Types

3.4.1 Osteoarthritis Pain Manufacturers Manufacturing Base Distribution, Headquarters

3.4.2 Manufacturers Osteoarthritis Pain Product Type

3.4.3 Date of International Manufacturers Enter into Osteoarthritis Pain Market

3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

4.1 Global Osteoarthritis Pain Sales by Product

4.2 Global Osteoarthritis Pain Revenue by Product

4.3 Osteoarthritis Pain Price by Product

5 Breakdown Data by End User

5.1 Overview

5.2 Global Osteoarthritis Pain Breakdown Data by End User

6 North America

6.1 North America Osteoarthritis Pain by Countries

6.1.1 North America Osteoarthritis Pain Sales by Countries

6.1.2 North America Osteoarthritis Pain Revenue by Countries

6.1.3 United States

6.1.4 Canada

6.1.5 Mexico

6.2 North America Osteoarthritis Pain by Product

6.3 North America Osteoarthritis Pain by End User

7 Europe

7.1 Europe Osteoarthritis Pain by Countries

7.1.1 Europe Osteoarthritis Pain Sales by Countries

7.1.2 Europe Osteoarthritis Pain Revenue by Countries

7.1.3 Germany

7.1.4 France

7.1.5 UK

7.1.6 Italy

7.1.7 Russia

7.2 Europe Osteoarthritis Pain by Product

7.3 Europe Osteoarthritis Pain by End User

8 Asia Pacific

8.1 Asia Pacific Osteoarthritis Pain by Countries

8.1.1 Asia Pacific Osteoarthritis Pain Sales by Countries

8.1.2 Asia Pacific Osteoarthritis Pain Revenue by Countries

8.1.3 China

8.1.4 Japan

8.1.5 Korea

8.1.6 India

8.1.7 Australia

8.1.8 Indonesia

8.1.9 Malaysia

8.1.10 Philippines

8.1.11 Thailand

8.1.12 Vietnam

8.1.13 Singapore

8.2 Asia Pacific Osteoarthritis Pain by Product

8.3 Asia Pacific Osteoarthritis Pain by End User

9 Central & South America

9.1 Central & South America Osteoarthritis Pain by Countries

9.1.1 Central & South America Osteoarthritis Pain Sales by Countries

9.1.2 Central & South America Osteoarthritis Pain Revenue by Countries

9.1.3 Brazil

9.2 Central & South America Osteoarthritis Pain by Product

9.3 Central & South America Osteoarthritis Pain by End User

10 Middle East and Africa

10.1 Middle East and Africa Osteoarthritis Pain by Countries

10.1.1 Middle East and Africa Osteoarthritis Pain Sales by Countries

10.1.2 Middle East and Africa Osteoarthritis Pain Revenue by Countries

10.1.3 GCC Countries

10.1.4 Turkey

10.1.5 Egypt

10.1.6 South Africa

10.2 Middle East and Africa Osteoarthritis Pain by Product

10.3 Middle East and Africa Osteoarthritis Pain by End User

11 Company Profiles

11.1 Abbott Laboratories

11.1.1 Abbott Laboratories Company Details

11.1.2 Company Business Overview

11.1.3 Abbott Laboratories Osteoarthritis Pain Sales, Revenue and Gross Margin (2014-2019)

11.1.4 Abbott Laboratories Osteoarthritis Pain Products Offered

11.1.5 Abbott Laboratories Recent Development

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Details

11.2.2 Company Business Overview

11.2.3 Johnson & Johnson Osteoarthritis Pain Sales, Revenue and Gross Margin (2014-2019)

11.2.4 Johnson & Johnson Osteoarthritis Pain Products Offered

11.2.5 Johnson & Johnson Recent Development

11.3 Novartis International

11.3.1 Novartis International Company Details

11.3.2 Company Business Overview

11.3.3 Novartis International Osteoarthritis Pain Sales, Revenue and Gross Margin (2014-2019)

11.3.4 Novartis International Osteoarthritis Pain Products Offered

11.3.5 Novartis International Recent Development

11.4 Pfizer

11.4.1 Pfizer Company Details

11.4.2 Company Business Overview

11.4.3 Pfizer Osteoarthritis Pain Sales, Revenue and Gross Margin (2014-2019)

11.4.4 Pfizer Osteoarthritis Pain Products Offered

11.4.5 Pfizer Recent Development

11.5 AbbVie

11.5.1 AbbVie Company Details

11.5.2 Company Business Overview

11.5.3 AbbVie Osteoarthritis Pain Sales, Revenue and Gross Margin (2014-2019)

11.5.4 AbbVie Osteoarthritis Pain Products Offered

11.5.5 AbbVie Recent Development

11.6 Abiogen Pharma

11.6.1 Abiogen Pharma Company Details

11.6.2 Company Business Overview

11.6.3 Abiogen Pharma Osteoarthritis Pain Sales, Revenue and Gross Margin (2014-2019)

11.6.4 Abiogen Pharma Osteoarthritis Pain Products Offered

11.6.5 Abiogen Pharma Recent Development

11.7 Afferent Pharmaceuticals

11.7.1 Afferent Pharmaceuticals Company Details

11.7.2 Company Business Overview

11.7.3 Afferent Pharmaceuticals Osteoarthritis Pain Sales, Revenue and Gross Margin (2014-2019)

11.7.4 Afferent Pharmaceuticals Osteoarthritis Pain Products Offered

11.7.5 Afferent Pharmaceuticals Recent Development

11.8 Astellas Pharma

11.8.1 Astellas Pharma Company Details

11.8.2 Company Business Overview

11.8.3 Astellas Pharma Osteoarthritis Pain Sales, Revenue and Gross Margin (2014-2019)

11.8.4 Astellas Pharma Osteoarthritis Pain Products Offered

11.8.5 Astellas Pharma Recent Development

11.9 BioDelivery Sciences International

11.9.1 BioDelivery Sciences International Company Details

11.9.2 Company Business Overview

11.9.3 BioDelivery Sciences International Osteoarthritis Pain Sales, Revenue and Gross Margin (2014-2019)

11.9.4 BioDelivery Sciences International Osteoarthritis Pain Products Offered

11.9.5 BioDelivery Sciences International Recent Development

11.10 Crystal Genomics

11.10.1 Crystal Genomics Company Details

11.10.2 Company Business Overview

11.10.3 Crystal Genomics Osteoarthritis Pain Sales, Revenue and Gross Margin (2014-2019)

11.10.4 Crystal Genomics Osteoarthritis Pain Products Offered

11.10.5 Crystal Genomics Recent Development

11.11 Cytori Therapeutics

12 Future Forecast

12.1 Osteoarthritis Pain Market Forecast by Regions

12.1.1 Global Osteoarthritis Pain Sales Forecast by Regions 2019-2025

12.1.2 Global Osteoarthritis Pain Revenue Forecast by Regions 2019-2025

12.2 Osteoarthritis Pain Market Forecast by Product

12.2.1 Global Osteoarthritis Pain Sales Forecast by Product 2019-2025

12.2.2 Global Osteoarthritis Pain Revenue Forecast by Product 2019-2025

12.3 Osteoarthritis Pain Market Forecast by End User

12.4 North America Osteoarthritis Pain Forecast

12.5 Europe Osteoarthritis Pain Forecast

12.6 Asia Pacific Osteoarthritis Pain Forecast

12.7 Central & South America Osteoarthritis Pain Forecast

12.8 Middle East and Africa Osteoarthritis Pain Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

13.1 Market Opportunities and Drivers

13.2 Market Challenges

13.3 Market Risks/Restraints

13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

14.1 Value Chain Analysis

14.2 Osteoarthritis Pain Customers

14.3 Sales Channels Analysis

14.3.1 Sales Channels

14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.2 Data Source

16.2 Author Details

16.3 Disclaimer

Please fill the form below, to recieve the report sample

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*

Please fill the form below for enquiry

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*
Choose License Type



Why Choose Us

  24/7 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Email: sales@magnifierresearch.com

Phone: +1-201-465-4211

  Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

  Information security

Your personal and confidential information is safe and secure.